Biotechnology News

April 16, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Theranos, Inc. today announced the appointment of William H. Frist, M.D., to its Board of Directors. Senator Frist is a nationally recognized heart and lung transplant surgeon, former U.S. Senate Majority...

April 16, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe, the leading personal genetics company, today announced the appointment of Dr. Jill Hagenkord as chief medical officer.

April 16, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter's Phase 3 study of its investigational recombinant treatment BAX 111, met its primary endpoint of success in treating bleeding events for patients with hereditary von Willebrand disease.

April 16, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides has been awarded the prestigious "IAIR Award" as the “Best North American Company for Leadership in the Nanomedicine Sector.”

April 16, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its first quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, May 1, 2014. The schedules for the press release and...

April 16, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today the appointment of Todd Bazemore as Executive Vice President and Chief Commercial Officer. Mr. Bazemore will be responsible for leading Dyax’s commercial organization...

April 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014, before the market opens. Following the announcement, at 8:30 a.m...

April 16, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today reported sales and net earnings for the first quarter ended March 29, 2014. First quarter highlights: Constant currency sales increased 4 percent and adjusted net earnings...

April 16, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced successful completion of the last licensure-enabling study in its BioThrax® (Anthrax Vaccine Adsorbed) Post-Exposure Prophylaxis (PEP) program. This clinical...

April 16, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart is post-acute care health information technology founding member of Carequality health data exchange initiative

April 16, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patents RE44846 and RE44847. These patents are reissued versions of U.S. Patents 7,744,582, and 7,776,015. Tracing back to inventions made in...

April 16, 2014

BOSTON--(BUSINESS WIRE)--Zalicus and Epirus announce Merger to Create a Publicly Traded, Global Biosimilar Enterprise Focused on Improving Patient Access to Important Medicines

April 16, 2014

BOSTON--(BUSINESS WIRE)--Epirus Biopharmaceuticals, Inc. (Epirus), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, and Zalicus Inc. (NASDAQ:ZLCS) (Zalicus),...

April 16, 2014

BOSTON--(BUSINESS WIRE)--Epirus Biopharmaceuticals, Inc. (Epirus), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that it has closed a $36...

April 16, 2014

VILLEJUIF, France--(BUSINESS WIRE)--ASCO, ESMO, EORTC, ESO & UICC endorse the WIN 2014 Symposium dedicated to combined targeted therapies. Keynotes lectures: Robert Weinberg, Leroy Hood, Guido Kroemer, Scott Serota, John Mendelsohn.

April 16, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--RBCC Bioprinting Partner Expands Brand Awareness Campaign

April 16, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife Sweden AB (STO:VITR) Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January - March 2014. The presentation will be held in...

April 16, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA® (eszopiclone) tablets C-IV in the US...

April 16, 2014

STOCKHOLM--(BUSINESS WIRE)--A study published in the Radiotherapy & Oncology Journal has shown that the use of Mepitel Film® dressings prevents the development of moist desquamation: painful skin ulcerations associated with breast cancer...

April 16, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative company specialized in the development of drugs within orphan oncology diseases, and Topotarget A/S (NASDAQ OMX - TOPO) a...

April 15, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2014 financial results will be released on Tuesday, April 22, at 4:05 p.m. Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s...

April 15, 2014

HALIFAX, Nova Scotia--(BUSINESS WIRE)--BioMag 2014, the world’s largest conference on the science of biomagnetism, pulls into Halifax, Nova Scotia at the end of August. The scientific program for the 19th biennial installment focuses on...

April 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission

April 15, 2014

WASHINGTON--(BUSINESS WIRE)--The 2014 BIO International Convention® will highlight the role of academia in the advancement of the biotechnology field through the BIO Alliance Pavilion and the Translational Research Forum.

April 15, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics Announces First U.S. Commercial Sale of MONOVISC® by the Company’s Commercial Partner, DePuy Synthes Mitek Sports Medicine.

April 15, 2014

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--The CVS poster will cover the development progress of Applied BioCode’s new high throughput multiplex system in addition to a 16-plex Gastrointestinal Pathogen Panel that currently is in development.

April 15, 2014

EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) publishes audited1 annual results for the fiscal year ended December 31st, 2013. The results were validated by the Board of Directors on April 15th, 2014. Key...

April 15, 2014

AMHERST, Mass.--(BUSINESS WIRE)--UMass Amherst's New Models to Medicine Center will hold its inaugural symposium, May 2, 2014, featuring four prominent scientists sharing experiences translating basic research into new therapies

April 15, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Lunesta® (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Lunesta® Tablets, marketed by Sunovion...

April 15, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces that a research...

April 15, 2014

HIGH POINT, N.C.--(BUSINESS WIRE)--TransTech Pharma, LLC (“TransTech”) announced today that effective March 28, 2014, Stephen L. Holcombe, who previously served as the Company’s Senior Vice President and Chief Financial Officer, has been...

April 15, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729), a medical technology company specializing in vertebral and knee-surgery implants, today announces the Board of Directors’ decision to appoint Mr Brian...

April 15, 2014

BERNARDSVILLE, N.J.--(BUSINESS WIRE)--PanOptica, Inc., a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, today announced that it has raised up to $45 million in a Series B round.

April 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of...

April 15, 2014

WASHINGTON & CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--BioPharm America™ 2014 returns to Boston’s Copley Place and a celebration of the FierceBiotech Fierce 15. More info at...

April 15, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth today announced the launch of its new blog, Targeting Cancer. The blog shares expert perspectives on the fast-moving changes in cancer treatment and engages in a broader conversation about...

April 15, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Total spending on U.S. medicines increased 1.0 percent on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued...

April 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven diseases, today announced the appointment of Karen J. Ferrante, M.D....

April 15, 2014

ST. LOUIS--(BUSINESS WIRE)--Synchrogenix acquisition adds global regulatory writing and submission services to Certara’s drug development consulting expertise.

April 15, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its first quarter 2014 financial results at 4:00 p.m. ET on Tuesday, April 22, 2014. In connection with this announcement, Cubist will host a conference...

April 15, 2014

KEARNEY, Neb.--(BUSINESS WIRE)--SCORR Marketing, a global leader in marketing communications, recently conducted a survey to assess marketing trends for the drug development services industry.

April 15, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Alzheon announced the United States Patent and Trademark Office (US PTO) issued a notice of allowance for 11/871,639. The allowed claims are directed to Alzheon’s lead therapeutic candidate ALZ-801.